Zealand Pharma A/S
CSE:ZEAL

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
CSE:ZEAL
Watchlist
Price: 430.7 DKK -0.07% Market Closed
Market Cap: 30.6B DKK

EV/OCF
Enterprise Value to OCF

-24.3
Current
-21.1
Median
4
Industry
Lower than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-24.3
=
Enterprise Value
22.6B DKK
/
Operating Cash Flow
-930.8m DKK
Market Cap EV/OCF
DK
Zealand Pharma A/S
CSE:ZEAL
30.4B DKK -24.3
FR
Pharnext SCA
OTC:PNEXF
6T USD -221 489.9
US
Abbvie Inc
NYSE:ABBV
309B USD 19.3
US
Amgen Inc
NASDAQ:AMGN
153.5B USD 17.2
US
Gilead Sciences Inc
NASDAQ:GILD
129.1B USD 13.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
124.4B USD -237.2
US
Epizyme Inc
F:EPE
94.1B EUR -508.3
AU
CSL Ltd
ASX:CSL
112.9B AUD 26.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
60.7B USD 8.8
US
Seagen Inc
F:SGT
39.3B EUR -79.7
NL
argenx SE
XBRU:ARGX
30.5B EUR -120.5
 
DK
Zealand Pharma A/S
CSE:ZEAL
Average EV/OCF: 17.1
Negative Multiple: -24.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -221 489.9
US
Abbvie Inc
NYSE:ABBV
19.3
US
Amgen Inc
NASDAQ:AMGN
17.2
US
Gilead Sciences Inc
NASDAQ:GILD
13.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -237.2
US
E
Epizyme Inc
F:EPE
Negative Multiple: -508.3
AU
CSL Ltd
ASX:CSL
26.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
8.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -79.7
NL
argenx SE
XBRU:ARGX
Negative Multiple: -120.5

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A